Cargando…
The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke
INTRODUCTION: Platelet activation plays a key role in the pathogenesis of ischemic cerebrovascular diseases. Thus, it is very important to identify novel pharmacological targets for platelet inhibition to improve ischemic stroke treatment. The aim of the study was to assess the relationship between...
Autores principales: | Pawelczyk, Malgorzata, Kaczorowska, Beata, Baj, Zbigniew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575219/ https://www.ncbi.nlm.nih.gov/pubmed/28883845 http://dx.doi.org/10.5114/aoms.2017.65816 |
Ejemplares similares
-
The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke
por: Pawelczyk, Malgorzata, et al.
Publicado: (2015) -
Surface expression of P-selectin on platelets is related with clinical worsening in acute ischemic stroke.
por: Cha, Jae-Kwan, et al.
Publicado: (2002) -
Association between plasma soluble P-selectin elements and progressive ischemic stroke
por: WANG, QIAN, et al.
Publicado: (2013) -
Effect of statins on platelet function in patients with hyperlipidemia
por: Sikora, Joanna, et al.
Publicado: (2013) -
Plasma P‐selectin is an early marker of thromboembolism in COVID‐19
por: Fenyves, Bánk G., et al.
Publicado: (2021)